Results 191 to 200 of about 2,310,959 (353)
PERSONAL ADAPTABILITY AS AN INTEGRATIVE FEATURE OF CADETS’ ADAPTATION TO TRAINING IN MILITARY INSTITUTIONS OF INTERNAL TROOPS OF THE MIA OF RUSSIA [PDF]
openalex +1 more source
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
Artificial Intelligence in Rheumatology: Clinical Applications in Rheumatoid Arthritis, Osteoarthritis, and Systemic Lupus Erythematosus. [PDF]
Aldhuaina K +11 more
europepmc +1 more source
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim +18 more
wiley +1 more source
Predicting NMR Relaxation Using a First-Principles Brownian Dynamics Approach. [PDF]
Zerbetto M, Rampino S, Polimeno A.
europepmc +1 more source
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rates (ASYRs) for site‐specific OA across 204 countries and territories were obtained from the Global Burden of Diseases, Injuries, and ...
Haowei Chen +14 more
wiley +1 more source
Imaging findings and complications after curettage of atypical cartilaginous tumors in long bones: a retrospective single-center cohort study. [PDF]
Gitto S +12 more
europepmc +1 more source
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla +13 more
wiley +1 more source

